Apple Tree Partners / Pfizer / Takeda Pharmaceuticals / Tokai Pharmaceuticals Inc. / Progenics Pharmaceuticals / Bristol-Myers Squibb Company / The Takeda Oncology Company / Tokai Pharmaceuticals Tokai Pharmaceuticals / Millennium Pharmaceuticals / /
Country
United States / /
Event
Employment Change / Funding / /
Facility
New England Deaconess Hospital / Georgetown University / Providence College / Beth Israel Deaconess Hospital / /
IndustryTerm
biopharmaceutical / pharmaceutical industry / treatment of castration-resistant prostate cancer / /
MedicalCondition
castration-resistant prostate cancer / seizures / diseases / prostate cancer / /
Organization
Harvard Medical School / Novartis Venture Fund / Beth Israel Deaconess Hospital / Georgetown University / New England Deaconess Hospital in Boston / Providence College / Satter Foundation / /
Person
Beth Israel Deaconess / Jodie Morrison / Karen J. Ferrante / /
Position
author / driver / vice president and therapeutic area clinical leader in oncology development / Chief Medical Officer / oncology therapeutic area head / associate director of clinical oncology / chief medical officer and a head of R&D / member of the board / president and chief executive officer / Head / site head / instructor / /
NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer CAMBRIDGE, Mass., April 15, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical